Skip to main content

Specialty Pharmacy

  • ABC posts 3% revenue gain with $80.2 billion in sales

    VALLEY FORGE, Pa. — AmerisourceBergen on Tuesday recorded revenues of $20.4 billion for fourth quarter 2011 ended Sept. 30, up 3.5%. Diluted earnings per share increased 8% to 54 cents. For the year, AmerisourceBergen posted $80.2 billion in revenue, up 2.9%.

  • CareFirst BlueCross BlueShield, Cardinal Health develop clinical pathways program for RA

    BALTIMORE — CareFirst BlueCross BlueShield and Cardinal Health Specialty Solutions on Tuesday launched the nation's first clinical pathways program for rheumatoid arthritis, a chronic disease that leads to inflammation of the joints and surrounding tissue and affects nearly 2.1 million Americans each year.

  • Pfizer could lose No. 1 global sales ranking to Sanofi next year, report finds

    LONDON — Pfizer soon may lose its distinction of having the highest global sales of any drug company, according to life sciences industry analysis firm EvaluatePharma.

    The next contender for the title is France's Sanofi, which EvaluatePharma said was expected to take the top spot next year and stay there through 2016.

  • Obama issues executive order to address drug shortages

    WASHINGTON — President Barack Obama issued an executive order Monday to address the growing problem of drug shortages.

  • Court injunction stops Watson, Amphastar from marketing, selling Lovenox generic

    PARSIPPANY, N.J. — Watson Pharmaceuticals and a partnering company are barred from launching a generic version of a blood-thinning drug under a federal court decision issued Friday.

  • Omnicare appoints SVP, general manager for RxCrossroads

    COVINGTON, Ky. — The VP distribution operations for Omnicare's RxCrossroads business has stepped into a new role, Omnicare announced Tuesday.

    Dan Thomas was appointed to the role of SVP and general manager for RxCrossroads, an Omnicare division that provides specialized solutions specifically tailored to the biotechnology and pharmaceutical industries. Thomas, who has worked in the unit for 27 years, will have full operational responsibility in his new role and report to Nitin Sahney, EVP and president of Omnicare’s Specialty Care Group.

  • Nycomed US announces executive changes

    MELVILLE, N.Y. — In line with its new position as a stand-alone corporation, the former U.S. subsidiary of a Swiss drug maker has appointed a new leader.

    Nycomed US announced that Brian Markison, former chairman and CEO of King Pharmaceuticals, will lead the company as president, CEO and a member of the board. The company also appointed Jeff Bailey as COO and John Golubieski as CFO. Both Bailey and Golubieski also held executive roles at King.

  • Specialty pharmacy group urges regulators to oppose ESI-Medco acquisition

    WASHINGTON — The ink has barely dried on the acquisition agreement between pharmacy benefit management giants Express Scripts and Medco Health Solutions, but several groups already are seeing smudges — most recently, a trade organization representing independent specialty pharmacy providers.

X
This ad will auto-close in 10 seconds